CORD-19:fccc2cff358d6c08f512003b88bab9934e4ffa7a / 14086-14304 JSONTXT

{"target":"http://pubannotation.org/docs/sourcedb/CORD-19/sourceid/fccc2cff358d6c08f512003b88bab9934e4ffa7a","sourcedb":"CORD-19","sourceid":"fccc2cff358d6c08f512003b88bab9934e4ffa7a","text":"As shown in Figure 1A , 3HP-β-LG exhibited potent anti-HPV activity in a dose-dependent manner with an IC 50 (the half maximal inhibitory concentration) of 0.59 μg/ml, which is more potent than that of 3HP-HSA (IC 50 :","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T96","span":{"begin":0,"end":218},"obj":"Sentence"},{"id":"TextSentencer_T96","span":{"begin":0,"end":218},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"TextSentencer_T96","pred":"source","obj":"CORD-19-Sentences"},{"subj":"TextSentencer_T96","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T32","span":{"begin":206,"end":209},"obj":"Disease"},{"id":"T58873","span":{"begin":206,"end":209},"obj":"Disease"}],"attributes":[{"id":"A32","pred":"mondo_id","subj":"T32","obj":"http://purl.obolibrary.org/obo/MONDO_0011848"},{"id":"A40033","pred":"mondo_id","subj":"T58873","obj":"http://purl.obolibrary.org/obo/MONDO_0011848"},{"subj":"T32","pred":"source","obj":"CORD-19-PD-MONDO"},{"subj":"T58873","pred":"source","obj":"CORD-19-PD-MONDO"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#93eca9","default":true},{"id":"CORD-19-PD-MONDO","color":"#ec9397"}]}]}}